|
MAPK7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1311000003289E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42629999999588E-06 |
| Normal-vs-Stage2 |
8.327700E-02 |
| Normal-vs-Stage3 |
2.761700E-03 |
| Normal-vs-Stage4 |
7.385400E-01 |
| Stage1-vs-Stage2 |
1.522010E-01 |
| Stage1-vs-Stage3 |
7.426400E-01 |
| Stage1-vs-Stage4 |
1.493930E-02 |
| Stage2-vs-Stage3 |
1.829450E-01 |
| Stage2-vs-Stage4 |
1.640620E-01 |
| Stage3-vs-Stage4 |
3.065600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.52749999818391E-08 |
| Normal-vs-AfricanAmerican |
4.197700E-03 |
| Normal-vs-Asian |
7.954800E-01 |
| Caucasian-vs-AfricanAmerican |
1.070430E-02 |
| Caucasian-vs-Asian |
1.369020E-01 |
| AfricanAmerican-vs-Asian |
3.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41629999950155E-07 |
| Normal-vs-Female |
3.91830000000537E-05 |
| Male-vs-Female |
8.265600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.729600E-02 |
| Normal-vs-Extreme_Weight |
6.15689999999836E-05 |
| Normal-vs-Obese |
2.84819999996078E-06 |
| Normal-vs-Extreme_Obese |
2.753900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.238600E-01 |
| Normal_Weight-vs-Obese |
6.211800E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.238800E-01 |
| Extreme_Weight-vs-Obese |
4.433600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.683400E-01 |
| Obese-vs-Extreme_Obese |
9.221400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.582600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.84899997932331E-09 |
| Normal-vs-Age(61-80Yrs) |
3.54780000000332E-05 |
| Normal-vs-Age(81-100Yrs) |
9.099600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.729800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.946800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.693900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.696400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.004500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.020300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.82369674917027E-11 |
| Normal-VS-Type2 PRCC |
2.795800E-01 |
| Normal-VS-KIRP CIMP |
3.833200E-01 |
| Normal-VS-Unclassified PRCC |
2.11459999999164E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.71589997555577E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.158080E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.678600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.316000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.597000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
4.138100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.378700E-03 |
| Normal-vs-N1 |
2.910300E-02 |
| Normal-vs-N2 |
2.701600E-01 |
| N0-vs-N1 |
9.030800E-01 |
| N0-vs-N2 |
7.087400E-01 |
| N1-vs-N2 |
7.585400E-01 |
|
|
